يهدف مركز معلومات التكنولوجيا الحيوية إلى توصيل مفهوم التكنولوجيا الحيوية والهندسة الوراثية وتطبيقاتها إلى كل فئات المجتمع وتنمية مداركه في هذا الشأن ، كما أنه يقوم بدور هام في إيضاح  كل من الفوائد والمخاطر المحتملة - إن وجدت - والتي يمكن أن تنتج عن تطبيقات التكنولوجيا الحيوية، من خلال حوار يتسم بالعقلانية والشفافية

Home

 

ISNAR

 

 

Introduction: 

BIOSAFETY  is one term that is used to describe the policies procedures adopted to ensure the environmentally safe application of modern biotechnology.It is a term that is gaining wider currency as more countries seek to benefit from the application of modern science in agriculture, medicine, and the environment, without endangering public health or environmental safety.

Egypt’s national biosafety system was formally instituted by the Ministry of Agriculture and Land Reclamation (MALR) in two decrees issued early 1995. Ministerial Decree No. 85 (January 25,1995) establishes a National Biosafety Committee (NBC); Ministerial Decree No. 136 (February 7,1995) adopted biosafety regulations and guidelines for Egypt.        

 

 

BIOSAFETY COMMITTEE

 

1. National Biosafety Committee (NBC):

An Egyption National Biosafety Committee is established, comprising policy makers and designers,scientific experts in Agricilture,Health,Industry and Environment from government and academic research institutes as well as experts from private sector.

 

1.1Roles And Responsibilities Of (NBC):

The purpose of the National Biosafety Committee is to establish policies and procedures to govern the use of modern biotechnology in the country.This includes publishing the National Biosafety Committee guidelines(NBC Guidelines) to be followed at the national level.The committee would also provide technical advice to the regulatory authorities and the institutions responsible for the development of the biotechnology in the country.

 

 

1.2 National Biosafety Committee Members:

In order to ensure the competence necessary to set biosafety policies at the national level it is recommended that the NBC include:

           Representative/s from the Ministry of Agriculture.

           Representative/s from The Ministry of Education.

           Representative/s from The Ministry of Industry.

           Representative/s from The Ministry of Health.

           Representative/s from The Sector of Environmental Affairs.

           Representative/s from The Private Sector.

           Policy makers and consultants knowledgeable in policies

           And applicable laws.

           Non-technical members who represent the interest of the

           surrounding community with respect to the health and

           Protection of the environment.

 

1.3 Activities Of NBC:

a) Formulate,implement and update safety codes.

b) Risk assessment and license issuance.

c) Coordination with international and national organizations.

d) Provide training and technical advice.

e) Report at least annually to governmental authorities.

 

1.4 Principal Investigator (PI):

The National Biosafety Committee would designate one or more principal investigators.

 

2. The Institutional Biosafety Committee (IBC):

The National Biosafety Committee should request that all institutions conducting R-DNA research assemble an Institutional Biosafety Committee.

 

2.1 Roles and Responsibilities of IBC:

The IBC is responsible for ensuring that the r-DNA research is carried out in full conformity with the provisions of the NBC Guidelines. As  part of its general responsibilities for implementing the NBC Guidelines,the IBC  may establish additional procedures as deemed

necessary to govern the institution activities.

 

2.2 Institutional Biosafety Committee Members:

In order to ensure the competence necessary to review R-DNA research activities,it is recommended that:

a) The IBC include persons with expertise in R-DNA technology that cover the research directions in the institute.

b) The IBC include persons with expertise in biological safety and physical containment.

c) The IBC have available as consultant's persons knowledgeable in institutional commitments, policies and applicable law.

d) IBC designate a Biologic Safety Officer (BSO) that meets the requirements set in section 1.4

 

2.3 Activities of IBC:

a) Assemble a comprehensive set of research and containment oriented guidelines that are tailored to the research activities   of the institute and the comply with the NBC Guidelines.

b) Establish a program for inspection to ensure that the physical containment facility continues to meet with the requirements.

c) Assessment of the facilities procedures,practices,and of the training and expertise of R-DNA personnel.

d) Review periodically R-DNA research being conducted at the institute to ensure that the requirements of the NBC Guidelines are being fulfilled.

 

2.4 Biological Safety Officer (BSO):

The institute should appoint a Biological Safety Officer who should be familiar with the biosafety requirements for the R-DNA work and the facilities. His duties include the following:

a) Enforces policies and regulations approved ensuring that these regulations are not compromised by other considerations.

b) Ensure through periodic inspections that laboratory standards are rigorously followed.

c) Ensure safety of laboratory work and prevent the accidental escape of R-DNA modified organisms.

d) Maintain a data base on all aspects of biosafety related to mandate crops.

e) Checks and gives advice on biosafety issues on a day to-day basis.

f)  Monitor worldwide biosafety requirements for R-DNA, also act as a member of the biosafety committee,reporting all related issues.

 

BIOSAFETY GUIDELINES

 

1.RISK ASSESSMENT:

Risk to the health of workers and others in the immediate vicinity of the work-place is one of the main concern in assessing the hazards associated with the contained use of GMOs.These risks are considered proportional to the scale of the operation and all regulatory systems distinguish small-scale use for research and development. As for large-scale use,the risk to health and possible risks to environment in the event of escape of organism from the production area must be evaluated and an appropriate level of containment applied.Containment may be physical,e.g.barriers limiting the escape of the organisms, or biological, e.g. physiological limitations to the survival and replication of the organism outside the process environment.

 

2.Determination of the Level of Safety Concern (LSC):

The Agriculture Biotechnology Research Advisory Committee (ABRAC) has recommended a step-wise process to the Assistant Secretary for Science and Education for the evaluation of level of safety concern of the Genetically Modified Organism into three levels.

Determining the level of safety concern is of great importance for analyzing the risks to human health and natural ecosystem for GMOs.

 

Step 1:Determine the level of safety concern of parental organism:

Depending on two criteria:

i. Whether the organism poses negligible risk to human health and no unreasonable risk to managed or natural ecosystem.

ii. The ability to manage or control the organism during its planned introduction into the environment so that the research is conducted in a safe manner.

 

Level 1 of safety Concern for parental Organisms:

The organism poses negligible risk to human health and no unreasonable risk to managed or natural ecosystem. Those organisms whose ecological attributes in the specified accessible environment are understood.

Some attributes in combination might indicate Level -1 organisms are:

 

a) No history of adverse effects in the accessible environment.

b) Low evolutionary potential to become harmful organism in the accessible environment.

c) Low probability of survival in the accessible environment.

 

Level 2 of safety Concern for parental Organisms:

Organisms whose ecological attributes in the accessible environment may pose a risk to human health that is not negligible or may pose an unreasonable risk to managed or natural ecosystem, which can and must be managed or controlled by appropriate confinement.

 

Level 3 of Safety Concern for parental Organisms:

Organisms whose ecological attributes in the accessible environment may pose a risk to human health that is not negligible or may pose an unreasonable risk to managed or natural ecosystem, and no feasible confinement will ensure safe conduct of the research outside contained facilities.

Some attributes in combination might indicate Level-3 organisms are:

a) History of adverse effect in the specified environment.

b) Ability to survive and proliferate in the environment.

c) Non-indigenous status in the environment.

d) High frequency of exchange of genetic information with adverse effect.

e) Lack of effective techniques to minimize the escape of the organisms.

f)  Lack of adequate techniques to recapture or kill escaped occurs.

 

Step 2: Determine the effect of the Genetic Modification on level of safety Concern:

The genetic modification should be evaluated in terms of its effect on the attribute of the parental organism evaluated in

step-1.where the genetic modification may have no effect on safety or increase or decrease safety.

The effect of the genetic modification on safety must be evaluated with reference to:

i.   Direct effect of the organism on human health or the environment.

ii.  Indirect effect of the organism through the substances it produces.

iii. Effects of genetic exchange with other organisms.

 

In step-2 investigators should examine the method of genetic modification; the molecular characterization and stability of the modified genes; the expression, function, and effects of the modified genes.

 

Type1:Genetic modification that Decrease Safety Concern for the  Modified organism:

Modifications that delete or disrupt the expression of a gene or genes, responsible for traits, such as, pathogenicity,fertility,survival, or fitness in a way that increase safety of the organism.

 

Type2:Genetic Modification that Have No Effect on Safety Concern for the Modified organism:

Sustainable understanding of the molecular biology and other information,including relevant experience, which shows that the modification is well characterized and that the gene functions and effects are adequately understood to predict safety.

 Modifications include:

i.  Insertions of nucleic acid,deletions, or rearrangement that have no phenotypic or genotypic consequences in the

    environment.

ii. Insertions of nucleic acid, deletions, or rearrangement that have known or predictable phenotypic or genotypic 

    consequences

    in the environment that unlikely may result in additional adverse effect to human health and the environment.

 

Type 3:Genetic Modification that Increase Safety Concern for the Modified organism.

Modifications include:

i.  Insertions of nucleic acid, deletions, or rearrangement that affect the expression of genes,but the functions or effects are not

    sufficiently understood to determine with certainly if the modified organism poses greater risk than the parental organism.

ii. Insertions of nucleic acid, deletions,or rearrangement that have known or predictable phenotypic or genotypic consequences

    in the environment that likely result in additional adverse effect on human health and the environment.

 

Step 3: Determination of the level of Safety Concern for Genetically Modified Organisms:

The genetically modified organisms should be assigned to one of three levels of safety concern by considering the effect of the genetic modification on safety, and if any affected attributes alter the level of safety concern for the modified organism compared to the parental organism.

The level of safety concern for the genetically modified organism is dependent on the same criteria applied to the determination of the level of Safety Concern for the parental organism.

 

Level-1 Parental Organism: 

i.  Level-1  of Safety Concern for the Parental Organism with type-I modification is considered as LSC-1 for the genetically

                   modified organism.

ii. Level-1  of Safety Concern for the Parental Organism with type-2 modification is considered as LSC-1 for the genetically

                   modified organism.

iii. Level-1 of Safety Concern for the Parental Organism with type-3 modification results in LSC-1,LSC-2,LSC-A genetically

                   modified organism, depending on the degree of safety concern as follows:

 

i.   If type-3 modification results in minimal increase in safety concern so that risk to human health remains negligible and risk to managed or natural ecosystem remains reasonable without the need for confinement measures, then the genetically modified organism remains LSC-1.

 

ii.  If type-3 modification increases safety concern to the extent that risk to human health is no longer negligible or risk to the  the environment is no longer reasonable, but feasible confinement measures are available to conduct research with negligible risk to human health and the environment, then the genetically modified organism is LSC-2.

 

iii. If type-3 modification increases safety concern to the extent that introduction into the environment cannot be adequately managed or controlled to achieve negligible risk to human health and no unreasonable risk to the environment, then the genetically modified is LSC-3.

 

Level -2 Parental Organism:

1)  Level-2  of Safety Concern for the Parental Organism with -1 modification results in LSC-1 or LSC-2 genetically modified organism,depending on the degree of safety concern as follows:

 

     i.  If type-1 modification decreases the safety concern to the extent that the organism poses negligible risk to human health and no unreasonable risk to managed or natural ecosystems without the need for confinement measures then the genetically modified organism is LSC-1.

 

     ii. If type-1 modification decreases the safety concern and risk to human health is negligible and risk to managed or natural ecosystems is reasonable only when managed by use of confinement measures, then the genetically modified

organism is LSC-2.

 

II)  Level-2 of Safety Concern for the Parental Organism with type-2 modifications,remains LSC-2 genetically modified organism.

Appropriate confinement measures are necessary for planned introduction into the environment.

 

III) Level-2 of Safety Concern for the Parental organism with type-3 modifications results in LSC-2 or LSC-3 genetically modified organism, depending on the degree of increase in safety concern as follows:

 

      i.  If type-3 modification increase safety concern,but planned introduction into the environment still can be managed or controlled by appropriate confinement measures,then the genetically modified organism is LSC-2.

 

      ii. If type-3 modification increases safety concern to the extent that there is not reasonable certainly that planned introduction into the environment can be managed or controlled,then the genetically modified organism is LSC-A,

Research must remain under confinement measures until there is a certainly that it could be controlled in a safe manner.

 

Level -3 Parental Organism: 

1)  Level-3 of Safety Concern for the Parental Organism with type-1 modification results in LSC-1,LSC-2,LSC-3 genetically modified organism, depending on the degree of decrease in safety concern as follows:

 

      i. If type -1 modification decreases safety concern to the extent that planned introduction into the environment poses negligible risk to human health and no unreasonable risk to managed or natural ecosystem without confinement measures, then the genetically modified organism is LSC-1.

 

      ii. If type-1 modification decreases safety concern, but confinement measures are necessary for the planned introduction into the environment with negligible risk to human health and no unreasonable risk to managed or natural ecosystem, then the genetically modified organism is LSC-2.

 

      iii.If type-1 modification decreases safety concern, but not to the extent that planned introduction of the organism can be managed or controlled to achieve negligible risk to human health and no unreasonable risk to managed or natural ecosystem, then the genetically modified organism is LSC-3.

Research must be conducted in a contained facility.

 

II) Level-3 of Safety Concern for the Parental Organism with type-2 or type-3 modification results in LSC-3 genetically modified organisms.       

 

3. BIOSAFETY GUIDELINES

 

Biosafety guidelines are designed to ensure that the products of biotechnology will not have adverse effect on the environment and agriculture,to prevent unintentional release of hazardous organisms,and to protect the surrounding communities as well as employees and researches involved.In the use of such products from the research stage till commercialization.

 

 

3.1 Biosafety Guidelines for laboratories:

Food storage,eating,drinking and smoking are prohibited in lab.

Mouth pipetting is prohibited.

Laboratory coats are obligatory and should be removed when exiting the lab.

Working surfaces must be decontaminated using soap and alcohol  after each working day.

waste products must be decontaminated by incinerating or by autoclaving.

Frequent hand wash is obligatory(at least one hand wash sink should be available).

Avoid contact with GMO's and other exotic biological agents,disposable gloves should be worn when handling such items.

Laboratory door should be closed at all times.

Working with fume-producing chemicals must be under the laboratory hood.

Biohazard warning signs should be always posted in labs.

 

3.2 Biosafety Guidelines For Containment Greenhouse:

Greenhouse should be locked at all times

Biosafety categories and safety codes should be posted at the greenhouse entrance.

Air circulation system should not allow dispersal of pollen or GMO's from greenhouse.

Non-living plant material,parts or viable exotic biological agents should leave the greenhouse expect for:

ـ Disposal,were it has to be autoclaved before its disposal.

ـ Storage in other facilities,in this case it should undergo adequate containment before transport.

The outgoing water must be chemically treated before its drainage.

Coats should be worn at all times in the greenhouse,and autoclaved before removal from the greenhouse for any reason.

Hand washing is required upon entering and exiting the greenhouse.

A disinfecting pad embedded with a decontaminating substance must be located the greenhouse entrance.

Daily record all experiments carried out in the greenhouse.

 

3.3 Biosafety Guidelines For Field Trials:

      (Small-Scale Field Testing):

Field experiments with exotic plant pest and pathogens are prohibited.

Plants must be prevented from spreading pollen by the removal of flowers.

If flowers are needed for testing and further experimentation,the inflorescence flowers must be covered before maturation.

Suitable plot isolation  must be provided avoiding pollen transmission to other near plots.

Special protective measures should be taken to ensure complete isolation of harvested plant parts.

Plots must be protected from the entry of animals or insects using bowered rows.                  

 

Top Page

Links | SiteMap | Website Statistic | Contact Us